BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24574781)

  • 1. Expression of granulocyte colony-stimulating factor receptor in rectal cancer.
    Yang XD; Huang P; Wang F; Xu ZK
    World J Gastroenterol; 2014 Jan; 20(4):1074-8. PubMed ID: 24574781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor receptor-1 overexpression is associated with poor response of rectal cancers to radiotherapy.
    Wu XY; Wu ZF; Cao QH; Chen C; Chen ZW; Xu Z; Li WS; Liu FK; Yao XQ; Li G
    World J Gastroenterol; 2014 Nov; 20(43):16268-74. PubMed ID: 25473182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly Expressed Granulocyte Colony-Stimulating Factor (G-CSF) and Granulocyte Colony-Stimulating Factor Receptor (G-CSFR) in Human Gastric Cancer Leads to Poor Survival.
    Fan Z; Li Y; Zhao Q; Fan L; Tan B; Zuo J; Hua K; Ji Q
    Med Sci Monit; 2018 Mar; 24():1701-1711. PubMed ID: 29567938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of epidermal growth factor receptor as a predictive factor for rectal cancer.
    Motlagh A; Azadeh P; Fazlalizadeh A; Shahrad B; Shafaghi B; Fudazi M; Yosefi A; Davaei M
    Arch Iran Med; 2007 Jul; 10(3):301-8. PubMed ID: 17604465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of nuclear β-catenin in rectal adenocarcinoma is associated with radioresistance.
    Wang L; Zhang XM; Li Z; Liu XJ; Chai J; Zhang GY; Cheng YF
    World J Gastroenterol; 2013 Oct; 19(40):6876-82. PubMed ID: 24187464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study.
    Senetta R; Duregon E; Sonetto C; Spadi R; Mistrangelo M; Racca P; Chiusa L; Munoz FH; Ricardi U; Arezzo A; Cassenti A; Castellano I; Papotti M; Morino M; Risio M; Cassoni P
    PLoS One; 2015; 10(4):e0123759. PubMed ID: 25875173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression pattern of telomerase reverse transcriptase in rectal carcinoma predicts tumor radiosensitivity, local recurrence and disease-free survival.
    Komuro Y; Watanabe T; Tsurita G; Muto T; Nagawa H
    Hepatogastroenterology; 2005; 52(64):985-9. PubMed ID: 16001613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma.
    Luna-Perez P; Arriola EL; Cuadra Y; Alvarado I; Quintero A
    Ann Surg Oncol; 1998; 5(3):203-8. PubMed ID: 9607618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of ATP-binding cassette subfamily C member 4 increases sensitivity to neoadjuvant radiotherapy for locally advanced rectal carcinoma.
    Yu ZQ; Zhang C; Wang H; Lao XY; Chai R; Gao XH; Cao GW; Fu CG
    Dis Colon Rectum; 2013 May; 56(5):600-8. PubMed ID: 23575399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of HER-2 in rectal cancers treated with preoperative radiotherapy: a potential biomarker predictive of metastasis.
    Yao YF; Du CZ; Chen N; Chen P; Gu J
    Dis Colon Rectum; 2014 May; 57(5):602-7. PubMed ID: 24819100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rsf-1 expression in rectal cancer: with special emphasis on the independent prognostic value after neoadjuvant chemoradiation.
    Lin CY; Tian YF; Wu LC; Chen LT; Lin LC; Hsing CH; Lee SW; Sheu MJ; Lee HH; Wang YH; Shiue YL; Wu WR; Huang HY; Hsu HP; Li CF; Chen SH
    J Clin Pathol; 2012 Aug; 65(8):687-92. PubMed ID: 22569540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biopsy specimens obtained 7 days after starting chemoradiotherapy (CRT) provide reliable predictors of response to CRT for rectal cancer.
    Suzuki T; Sadahiro S; Tanaka A; Okada K; Kamata H; Kamijo A; Murayama C; Akiba T; Kawada S
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1232-8. PubMed ID: 23158058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
    Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
    Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection.
    Rödel F; Hoffmann J; Grabenbauer GG; Papadopoulos T; Weiss C; Günther K; Schick C; Sauer R; Rödel C
    Strahlenther Onkol; 2002 Aug; 178(8):426-35. PubMed ID: 12240548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of granulocyte colony-stimulating factor receptor correlates with prognosis in oral and mesopharyngeal carcinoma.
    Tsuzuki H; Fujieda S; Sunaga H; Noda I; Saito H
    Cancer Res; 1998 Feb; 58(4):794-800. PubMed ID: 9485037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin, p53, and Ki-67 as predictors of histopathologic response in locally advanced rectal cancer treated with preoperative chemoradiotherapy.
    Terzi C; Canda AE; Sagol O; Atila K; Sonmez D; Fuzun M; Gorken IB; Oztop I; Obuz F
    Int J Colorectal Dis; 2008 Jan; 23(1):37-45. PubMed ID: 17805549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation.
    Guillem JG; Chessin DB; Shia J; Suriawinata A; Riedel E; Moore HG; Minsky BD; Wong WD
    Ann Surg; 2007 Jan; 245(1):88-93. PubMed ID: 17197970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Nomogram to Predict Lymph Node Positivity Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
    Newton AD; Li J; Jeganathan AN; Mahmoud NN; Epstein AJ; Paulson EC
    Dis Colon Rectum; 2016 Aug; 59(8):710-7. PubMed ID: 27384088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of neoadjuvant chemoradiotherapy on the rates of sphincter preserving surgery in lower rectal cancer and analysis of their prognostic factors].
    Wang XJ; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX
    Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):419-423. PubMed ID: 27938574
    [No Abstract]   [Full Text] [Related]  

  • 20. Neoadjuvant-intensified treatment for rectal cancer: time to change?
    Musio D; De Felice F; Bulzonetti N; Guarnaccia R; Caiazzo R; Bangrazi C; Raffetto N; Tombolini V
    World J Gastroenterol; 2013 May; 19(20):3052-61. PubMed ID: 23716984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.